Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Hungarian drugmaker Gedeon Richter has announced entering into a distribution and supply agreement with a wholly owned subsidiary of Allergan to commercialize its levonorgestrel-releasing intrauterine system (IUS) in Latin American countries.
The product in question is already marketed by Richter under the trademark of Levosert since 2011 in most of Europe through agreements established with Irish-registered Allergan, according to a press release sent to the Budapest Business Journal.
Sales-related royalties and milestone payments will become payable to Allergan subsequent to the launch of the product, Richter says.